As of 2025-07-04, the EV/EBITDA ratio of scPharmaceuticals Inc (SCPH) is -2.86. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SCPH's latest enterprise value is 203.08 mil USD. SCPH's TTM EBITDA according to its financial statements is -71.11 mil USD. Dividing these 2 quantities gives us the above SCPH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.1x - 8.0x | 7.6x |
| Forward P/E multiples | 8.1x - 14.3x | 10.8x |
| Fair Price | (10.76) - (10.65) | (12.24) |
| Upside | -371.1% - -368.4% | -408.2% |
| Date | EV/EBITDA |
| 2025-06-11 | -2.94 |
| 2025-06-10 | -3.08 |
| 2025-06-09 | -3.06 |
| 2025-06-06 | -3.03 |
| 2025-06-05 | -2.96 |
| 2025-06-04 | -2.97 |
| 2025-06-03 | -2.77 |
| 2025-06-02 | -2.76 |
| 2025-05-30 | -2.61 |
| 2025-05-29 | -2.54 |
| 2025-05-28 | -2.57 |
| 2025-05-27 | -2.54 |
| 2025-05-23 | -2.37 |
| 2025-05-22 | -2.51 |
| 2025-05-21 | -2.39 |
| 2025-05-20 | -2.35 |
| 2025-05-19 | -2.52 |
| 2025-05-16 | -2.30 |
| 2025-05-15 | -2.05 |
| 2025-05-14 | -1.57 |
| 2025-05-13 | -1.63 |
| 2025-05-12 | -1.75 |
| 2025-05-09 | -1.72 |
| 2025-05-08 | -1.77 |
| 2025-05-07 | -1.70 |
| 2025-05-06 | -1.61 |
| 2025-05-05 | -1.75 |
| 2025-05-02 | -1.84 |
| 2025-05-01 | -1.79 |
| 2025-04-30 | -1.80 |
| 2025-04-29 | -1.67 |
| 2025-04-28 | -1.73 |
| 2025-04-25 | -1.77 |
| 2025-04-24 | -1.76 |
| 2025-04-23 | -1.84 |
| 2025-04-22 | -1.85 |
| 2025-04-21 | -1.81 |
| 2025-04-17 | -1.82 |
| 2025-04-16 | -1.80 |
| 2025-04-15 | -1.87 |
| 2025-04-14 | -1.82 |
| 2025-04-11 | -1.63 |
| 2025-04-10 | -1.40 |
| 2025-04-09 | -1.53 |
| 2025-04-08 | -1.50 |
| 2025-04-07 | -1.64 |
| 2025-04-04 | -1.63 |
| 2025-04-03 | -1.62 |
| 2025-04-02 | -1.76 |
| 2025-04-01 | -1.64 |